SGCB and heart failure: The potential of direct sGC stimulators in heart failure might go beyond hemodynamic effects and additionally, or even predominantly, rely on non-hemodynamic effects of sGC-derived cGMP signalling in a variety of tissues including cardiac myocytes [16].